Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

Endpoint:
two-generation reproductive toxicity
Remarks:
based on test type (migrated information)
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Study period:
1996
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
GLP - Guideline study, tested with the source substance zinc(bis) dimethyldithiocarbamate (CAS No. 137-30-4). In accordance to the ECHA guidance document “Practical guide 6: How to report read-across and categories (March 2010)”, the reliability was changed from RL1 to RL2 to reflect the fact that this study was conducted on an read-across substance

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1996
Report date:
1996

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 416 (Two-Generation Reproduction Toxicity Study)
Deviations:
yes
Remarks:
- Not all required organ weights were determined. - Sperm parameters were not assessed for all animals.
GLP compliance:
yes
Limit test:
no

Test material

Constituent 1
Reference substance name:
Ziram
EC Number:
205-288-3
EC Name:
Ziram
Cas Number:
137-30-4
IUPAC Name:
zinc bis(dimethyldithiocarbamate)
Constituent 2
Reference substance name:
zinc bis dimethyldithiocarbamate
IUPAC Name:
zinc bis dimethyldithiocarbamate
Details on test material:
- Test material: Ziram
- Lot/Batch number: V528/8331 AA
- Description: White powder
- Purity: 97.8%
- Stability: Not reported.

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Breeding Laboratories, Portage, Michigan, USA
- Age at study initiation: 6 weeks
- Weight at study initiation: ♂: 144-218 g, ♀: 117-174

Administration / exposure

Route of administration:
oral: feed
Vehicle:
other: diet
Details on mating procedure:
- M/F ratio: 1:1
- Length of cohabitation: Up to 15 days
- Proof of pregnancy: vaginal plug or sperm in vaginal smear referred to as day 0 of gestation
- After 10 days of unsuccessful pairing replacement of first male by another male with proven fertility.
- Further matings after two unsuccessful attempts: no
- Any other deviations from standard protocol: Litters were culled to 8 pups/litter on lactation day 4.
Analytical verification of doses or concentrations:
yes
Duration of treatment / exposure:
F0 parents: from study initiation until scheduled sacrifice
F1 parents: from weaning (day 22) until scheduled sacrifice
F2 pups: from weaning (day 22) until scheduled sacrifice

Duration of exposure before mating (F0 / F1 parents): 10 weeks
Frequency of treatment:
Ad libitum
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 60*, 180#, 540 ppm (Concentration was increased to 72 ppm (*)/ 207 ppm (#) to compensate losses during storage)
Basis:
nominal in diet
No. of animals per sex per dose:
30
Control animals:
yes, plain diet
Details on study design:
- Actual doses
F0 ♂:
5, 15, 37 mg/kg/day (prior to breeding)
3, 10, 25 mg/kg/day (after breeding)

F0 ♀: 6, 17, 43 mg/kg/day (prior to breeding)
5, 13, 33 mg/kg/day (gestation)
12, 33, 85 mg/kg/day (lactation)
5, 15, 37 mg/kg/day (after weaning)

F1 ♂:
6, 18, 46 mg/kg/day (prior to breeding)
3, 10, 26 mg/kg/day (after breeding)

F1 ♀:
7, 20, 51 mg/kg/day (prior to breeding)
5, 13, 32 mg/kg/day (gestation)
11, 30, 79 mg/kg/day (lactation)
5, 14, 34 mg/kg/day (after weaning)
Positive control:
none

Examinations

Parental animals: Observations and examinations:
MORTALITY
- Twice daily

CLINICAL SIGNS
- Twice daily

BODY WEIGHT
- Weekly during treatment and prior to terminal sacrifice for males.
- Confirmed mated ♀ were weighed on presumed gestation Days 0, 7, 10, 14, and 20. Nursing dams were weighed on Days 1, 4, 7, 14, and 21 post partum. After weaning (day 22) once weekly until scheduled sacrifice.

FOOD CONSUMPTION
- Daily until pairing for all animals.
- Male food consumption was measured after mating again daily until scheduled sacrifice.
- Female food consumption was measured daily throughout gestation and lactation period.
- No food consumption data was obtained during the mating period.






Oestrous cyclicity (parental animals):
- Daily during mating.
Sperm parameters (parental animals):
- Only performed on males which were paired, but failed to sire a litter.
Litter observations:
- Sex-determination, pup viability, body weight gain, clinical signs, necropsy on dead pups, behavioural testing (F2)
Postmortem examinations (parental animals):
ORGAN WEIGHTS
- Yes
- Organs: testes + epididymides/ovaries, brain, pituitary gland, kidneys, liver

HISTOPATHOLOGY
- All animals from control and high-dose group.
- Tissues: Cervix, coagulating gland, epididymides, kidneys, liver, ovaries, pituitary gland, prostate, seminal vesicles, testes, uterus, vagina, vas deferens, all internal gross lesions
Postmortem examinations (offspring):
- neuropathological examination (F2)

Results and discussion

Results: P0 (first parental generation)

General toxicity (P0)

Clinical signs:
no effects observed
Body weight and weight changes:
effects observed, treatment-related
Food consumption and compound intake (if feeding study):
effects observed, treatment-related
Organ weight findings including organ / body weight ratios:
no effects observed
Histopathological findings: non-neoplastic:
no effects observed
Other effects:
no effects observed

Reproductive function / performance (P0)

Reproductive function: oestrous cycle:
no effects observed
Reproductive function: sperm measures:
no effects observed
Reproductive performance:
no effects observed

Details on results (P0)

F0 (♂+♀):
- Mean body weights and body weight gains in the 540 ppm group males were reduced early in the treatment period. In females mean body weights and body weight gains in the 540 ppm group were generally reduced throughout gestation and lactation and after weaning.
- Food consumption in the 540 ppm group was generally reduced in males and prior to breeding, during gestation and lactation and after weaning in females.

Effect levels (P0)

open allclose all
Dose descriptor:
NOAEL
Effect level:
ca. 10 mg/kg bw/day
Sex:
female
Basis for effect level:
other: (post-breeding intake ) = 10.4 mg KDDC (a.s.)/kg bw/day = 20.8 mg KDDC (50%)/kg bw/day
Remarks on result:
other: Generation: maternal (migrated information)
Dose descriptor:
NOAEL
Effect level:
ca. 10 mg/kg bw/day
Sex:
male/female
Basis for effect level:
other: (post-breeding intake) = 10.4 mg KDDC (a.s.)/kg bw/day = 20.8 mg KDDC (50%)/kg bw/day
Remarks on result:
other: Generation: neonatal (migrated information)
Dose descriptor:
NOAEL
Effect level:
ca. 25 mg/kg bw/day
Sex:
male/female
Basis for effect level:
other: (post-breeding intake) = 26.1 mg KDDC (a.s.)/kg bw/day = 52.2 mg KDDC (50%)/kg bw/day
Remarks on result:
other: Generation: reproduction (migrated information)

Results: F1 generation

General toxicity (F1)

Clinical signs:
no effects observed
Mortality / viability:
no mortality observed
Body weight and weight changes:
effects observed, treatment-related
Sexual maturation:
no effects observed
Organ weight findings including organ / body weight ratios:
no effects observed
Gross pathological findings:
no effects observed
Histopathological findings:
no effects observed

Details on results (F1)

F1 (♂+♀):
- Mean pup body weights in the 540 ppm group litters were slightly reduced during lactation. Mean body weights and body weight gains in the 540 ppm group males were reduced throughout the treatment period. In females mean body weights and body weight gains in the 540 ppm group were generally reduced throughout gestation and lactation and after weaning.
- Food consumption in the 540 ppm group was generally reduced in males and prior to breeding, during gestation and lactation and after weaning in females.
F2 (♂+♀):
- Mean pup body weights in the 540 ppm group litters were slightly reduced during lactation and throughout the remainder of the study until the postnatal day 70 neuropathology evaluation.

Overall reproductive toxicity

Reproductive effects observed:
not specified

Any other information on results incl. tables

Table 7.8.1-A1        Body weight changes in reproductive toxicity study

Parameter

Genera­tion

Controls

60 ppm

180 ppm

540 ppm

Dose-response

+/–

Body weight [g]

average weight on gestation
Day 14

F0 dams

/

348.4

/

338.6

/

356.0

/

343.8

/

F1 dams

/

357.1

/

339.1

/

344.7

/

316.7*

/

average pup weight on lactation Day 21

F1 pups

44.8

42.8

44.6

41.8

46.3

43.5

40.2*

37.7*

F2 pups

40.7

39.5

41.0

39.3

44.1

41.2

38.5

36.9

* statistically significant different from control p </= 0.05

Applicant's summary and conclusion